BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 236 filers reported holding BLUEBIRD BIO INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $208,000 | -44.2% | 6,501 | -24.5% | 0.00% | – |
| Q4 2020 | $373,000 | -70.1% | 8,609 | -62.8% | 0.00% | -100.0% |
| Q3 2020 | $1,249,000 | +8.5% | 23,160 | +22.8% | 0.00% | 0.0% |
| Q2 2020 | $1,151,000 | +102.6% | 18,860 | +52.7% | 0.00% | 0.0% |
| Q1 2020 | $568,000 | -20.2% | 12,355 | +52.3% | 0.00% | 0.0% |
| Q4 2019 | $712,000 | -31.7% | 8,113 | -28.5% | 0.00% | 0.0% |
| Q3 2019 | $1,042,000 | -20.3% | 11,351 | +10.4% | 0.00% | -50.0% |
| Q2 2019 | $1,308,000 | -11.3% | 10,281 | +9.8% | 0.00% | 0.0% |
| Q1 2019 | $1,474,000 | +64.0% | 9,366 | +3.3% | 0.00% | +100.0% |
| Q4 2018 | $899,000 | +1373.8% | 9,063 | +2241.9% | 0.00% | – |
| Q2 2018 | $61,000 | -4.7% | 387 | +2.7% | 0.00% | – |
| Q1 2018 | $64,000 | -1.5% | 377 | +2.7% | 0.00% | – |
| Q4 2017 | $65,000 | +44.4% | 367 | +13.6% | 0.00% | – |
| Q3 2017 | $45,000 | +309.1% | 323 | +201.9% | 0.00% | – |
| Q2 2017 | $11,000 | +10.0% | 107 | -7.8% | 0.00% | – |
| Q1 2017 | $10,000 | – | 116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |